WebApr 13, 2024 · The stock has a market capitalization of $4.27 billion, a P/E ratio of 45.70, a P/E/G ratio of 2.50 and a beta of 0.44. The company's fifty day moving average is $80.32 and its two-hundred day moving average is $80.60. Haemonetics Co. has a 1 year low of $48.67 and a 1 year high of $91.39. Haemonetics ( NYSE:HAE - Get Rating) last … WebCFO Haemonetics Corp. 1998 - 20079 years CFO, SVP Operations Converse Inc. 1990 - 19988 years CFO Europe, Middle East, Africa Bristol-Myers Squibb Co. 1984 - 19906 years Education Columbia...
Haemonetics Announces CFO William P. Burke
WebNov 9, 2024 · Mr. Burke joined Haemonetics as Chief Financial Officer in August 2016 after spending more than 20 years in finance and business leadership roles at leading … WebSenior finance professional at Haemonetics Corporation (NYSE: HAE), a $900 million revenue global healthcare company. Haemonetics is dedicated to providing a suite of innovative hematology... svjetsko prvenstvo u nogometu 1990
Haemonetics names new CFO (NYSE:HAE) Seeking Alpha
WebJul 1989 - Aug 19912 years 2 months. Hospital Supply and Scientific Products. Mid Atlantic Regional Operations Manager, Columbia, MD. ValueLink Hospital Account Executive, … WebApr 14, 2016 · Haemonetics Corporation. Apr 14, 2016, 04:01 ET. BRAINTREE, Mass., April 14, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Christopher Lindop, Chief Financial ... WebMar 13, 2024 · BRIAN P. CONCANNON has served as a Director of the Company since July 2013. Mr. Concannon served as President and CEO of Haemonetics Corporation, a publicly traded company (NYSE: HAE) headquartered in Braintree, Massachusetts, that provides blood management technologies and services to hospitals, blood collectors and … svjetsko prvenstvo u kosarci zene